The Obesity-Liver Connection
Joseph Zucchi, PA-C, MPAS
In this four-part educational series, PA Joseph Zucchi explores obesity as a chronic, multisystem disease and its close relationship with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
PA Zucchi covers the comorbidities of obesity, how MASLD progresses and who is at risk, how to stratify fibrosis risk using noninvasive tests, and current treatment options. You will gain practical strategies for screening patients proactively, setting treatment goals focused on overall health, and delivering compassionate care while minimizing weight bias.
Video 1: Obesity, A Multisystem Disease
Learn how obesity contributes to more than 200 comorbidities and why treatment goals should focus on overall health, not just weight.
Video 2: Recognizing MASLD Risk and Progression
Understand how MASLD progresses from steatosis to MASH and cirrhosis, and which risk factors should prompt PAs to screen for it.
Video 3: Assessing and Treating MASLD
Explore a two-tier, noninvasive approach to fibrosis risk stratification and the treatment options available for patients with MASLD and MASH.
Video 4: Overcoming Weight Bias and Stigma
Discover practical strategies to recognize your own weight bias, communicate respectfully, and create a more welcoming practice for patients in larger bodies.
Supported by
